Answers are grounded in this paper and cite their sources.
Progenitor cells or mesenchymal stem cells are new cells, with renovation and regeneration ability and tissues repair. In recent years, administration of stem cells has been introduced to treat a variety of diseases including chronic allograft injury (CAI). It seems that stem cells can create a turning point in regenerative medicine through repair, replacement with damaged tissues or with their paracrine effects.
No takes yet. Share an insight, caveat, or question.
Gholami et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: